Kawano S, Kamataki T, Maeda K, Kato R, Nakao T, Mizoguchi I
Fundam Appl Toxicol. 1985 Jun;5(3):487-98. doi: 10.1016/0272-0590(85)90096-x.
Six cytochrome P-450 preparations from phenobarbital (PB)-treated rats and two preparations from beta-naphthoflavone (BNF)-treated rats were purified. Using Salmonella typhimurium TA98 the ability of these cytochrome P-450 preparations to mutagenically activate and inactivate a variety of carcinogens was examined. High- and low-spin forms of cytochrome P-448 isolated from BNF-treated rats (BNF-IIa and IId) activated various carcinogens. Both forms activated 2-aminofluorene, benzo[a]pyrene, and dibenz[a,c]anthracene. However, o-aminoazotoluene and 2-nitrofluorene were activated only by the low-spin form, and aflatoxin B1 only by the high-spin form. In contrast, only limited carcinogens were activated by some preparations from PB-treated rats. 2-Aminofluorene was activated by four PB-inducible preparations (PB-Ia, Ic, Id, and IIa), but only moderately. Unexpectedly, however, the most prominent activation of benzo[a]pyrene was observed with one preparation (PB-Id) from PB-treated rats. Direct mutagens to the S. typhimurium, 4-NQO and AF-2, were markedly inactivated by NADPH-cytochrome c (P-450) reductase without cytochrome P-450. One PB-inducible form (PB-Ic) inactivated 2-nitrofluorene, and the high-spin form of P-448 (BNF-IIa) inactivated AF-2.